Investors: Lotus One Investment, VP Venture Partners, MEDIN Fund, N&V Capital, QAI Ventures
Swiss computer vision startup uses AI-powered image analysis for clinical oncology diagnostics, detecting genomic biomarkers from blood and cytology slides.